EGCG reduced the activity of MMP2 induced by IL6/soluble IL6 receptor complex through increasing the soluble gp130 synthesis, which led to the reduction in MMP2 activity in RA SFBs. This evidence concerns the gene MMP2 and rheumatoid arthritis.